3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
9
Neoplasms
3
Brain Neoplasms
3
Medulloblastoma
2
Glioma
2
Sarcoma
1
Recurrence
1
Pancreatic Neoplasms
1
Neoplasm Recurrence, Local
1
Neoplasm Metastasis
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Leukemia-Lymphoma, Adult T-Cell
1
Kidney Neoplasms
1
Hereditary Sensory and Autonomic Neuropathies
1
Gliosarcoma
1
Colorectal Neoplasms
1
Central Nervous System Neoplasms
1
Breast Neoplasms
1
Bone Neoplasms
1
Interventions
Cyclophosphamide
30
Rituximab
27
Biopsy
23
Specimen Handling
20
Magnetic Resonance Spectroscopy
18
fludarabine
14
Prednisone
13
Vincristine
11
obinutuzumab
10
Lenalidomide
10
Etoposide
10
Doxorubicin
10
Bendamustine Hydrochloride
9
venetoclax
7
pembrolizumab
7
fludarabine phosphate
6
X-Rays
6
Tacrolimus
6
Nuclear Medicine Department, Hospital
6
Dexamethasone
6
Bortezomib
6
trametinib
5
ibrutinib
5
glofitamab
5
acalabrutinib
5
Mycophenolic Acid
5
Gemcitabine
5
Crizotinib
5
Busulfan
5
copanlisib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
Lomustine
×
90 days
×
Clear all
No trials found.